Cargando…

Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System

The aim of the present study was to prepare, evaluate and optimize, self micro emulsifying drug delivery system of celecoxib. A 3 factor, 3 level factorial design was used for the optimization procedure with different amounts of Labrafil 2609 WL, Labrasol, and Cremophor EL as the independent variabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaji, Jessy, Lodha, Shital
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038281/
https://www.ncbi.nlm.nih.gov/pubmed/21394253
http://dx.doi.org/10.4103/0250-474X.45395
_version_ 1782198074585645056
author Shaji, Jessy
Lodha, Shital
author_facet Shaji, Jessy
Lodha, Shital
author_sort Shaji, Jessy
collection PubMed
description The aim of the present study was to prepare, evaluate and optimize, self micro emulsifying drug delivery system of celecoxib. A 3 factor, 3 level factorial design was used for the optimization procedure with different amounts of Labrafil 2609 WL, Labrasol, and Cremophor EL as the independent variables. The response variable was selected on particle size (nm) of the droplets after dilution in 0.1N HCl. Particle size of the self micro-emulsifying drug delivery system depends on the quantity of above three independent variables. Three different levels of each independent variable were selected for the optimization. Mathematical equation and response surface plots were used to relate the dependent and independent variables. The regression equation generated for the particle size after dilution was, Particle size (Y)= +27.83+76.07×A-23.62×B-43.83×C+52.72×A(2)+9.82×B(2)+27.20×C(2)-14.52×A×B-32.38×A×C+12.1×B×C, where, A=Labrafil 2609 WL, B= Labrasol, C= Cremophor EL, Y= particle size. The optimized model predicted a particle size of 28.33 nm with 0.16ml of labrafil 2609 WL, 0.17ml Labrasol and 0.22ml of Cremophor EL. The observed response were in close agreement with the predicted values of the optimized formulation. This demonstrates the reliability of the optimization procedure in predicting particle size of self microemulsifying delivery system for celecoxib.
format Text
id pubmed-3038281
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-30382812011-03-10 Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System Shaji, Jessy Lodha, Shital Indian J Pharm Sci Research Papers The aim of the present study was to prepare, evaluate and optimize, self micro emulsifying drug delivery system of celecoxib. A 3 factor, 3 level factorial design was used for the optimization procedure with different amounts of Labrafil 2609 WL, Labrasol, and Cremophor EL as the independent variables. The response variable was selected on particle size (nm) of the droplets after dilution in 0.1N HCl. Particle size of the self micro-emulsifying drug delivery system depends on the quantity of above three independent variables. Three different levels of each independent variable were selected for the optimization. Mathematical equation and response surface plots were used to relate the dependent and independent variables. The regression equation generated for the particle size after dilution was, Particle size (Y)= +27.83+76.07×A-23.62×B-43.83×C+52.72×A(2)+9.82×B(2)+27.20×C(2)-14.52×A×B-32.38×A×C+12.1×B×C, where, A=Labrafil 2609 WL, B= Labrasol, C= Cremophor EL, Y= particle size. The optimized model predicted a particle size of 28.33 nm with 0.16ml of labrafil 2609 WL, 0.17ml Labrasol and 0.22ml of Cremophor EL. The observed response were in close agreement with the predicted values of the optimized formulation. This demonstrates the reliability of the optimization procedure in predicting particle size of self microemulsifying delivery system for celecoxib. Medknow Publications 2008 /pmc/articles/PMC3038281/ /pubmed/21394253 http://dx.doi.org/10.4103/0250-474X.45395 Text en © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Papers
Shaji, Jessy
Lodha, Shital
Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System
title Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System
title_full Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System
title_fullStr Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System
title_full_unstemmed Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System
title_short Response Surface Methodology for the Optimization of Celecoxib Self-microemulsifying Drug delivery System
title_sort response surface methodology for the optimization of celecoxib self-microemulsifying drug delivery system
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038281/
https://www.ncbi.nlm.nih.gov/pubmed/21394253
http://dx.doi.org/10.4103/0250-474X.45395
work_keys_str_mv AT shajijessy responsesurfacemethodologyfortheoptimizationofcelecoxibselfmicroemulsifyingdrugdeliverysystem
AT lodhashital responsesurfacemethodologyfortheoptimizationofcelecoxibselfmicroemulsifyingdrugdeliverysystem